Table of Contents 2012-2023 Global ADHD Drugs Market Research Report by Manufacturers, Regions, Types and Applications 1 ADHD Drugs Market Overview 1.1 Product Overview and Scope of ADHD Drugs 1.2 ADHD Drugs Segment by Type (Product Category) 1.2.1 ADHD Drugs Segment by Types (Product Category) and Its Subclasses 1.2.2 Global ADHD Drugs Production Market Share by Type (Product Category) in 2016 1.2.3 Different Subclasses for Stimulants (Amphetamines, Methylphenidate) 1.2.3.1 Subclass 1 1.2.3.2 Subclass 2 1.2.3.3 Subclass 3 1.2.4 Different Subclasses for Non-Stimulants 1.2.4.1 Subclass 1 1.2.4.2 Subclass 2 1.2.4.3 Subclass 3 1.2.5 Different Subclasses for Antidepressants 1.2.5.1 Subclass 1 1.2.5.2 Subclass 2 1.2.5.3 Subclass 3 1.3 Global ADHD Drugs Segment by Application 1.3.1 Global ADHD Drugs Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Adults 1.3.3 Children 1.4 New Project SWOT Analysis of ADHD Drugs 1.5 Industry News Analysis of ADHD Drugs 2 Industrial Chain Analysis 2.1 Industry Chain Structure of ADHD Drugs 2.2 Raw Material Analysis of ADHD Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of ADHD Drugs 2.4 Other Costs Analysis of ADHD Drugs 2.5 Manufacturing Cost Structure Analysis of ADHD Drugs 2.6 Manufacturing Process Analysis of ADHD Drugs 2.7 Raw Materials Sources of ADHD Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of ADHD Drugs 3 Global ADHD Drugs Manufacturers Profiles/Analysis 3.1 Eli Lilly 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 ADHD Drugs Product Category, Application and Specification 3.1.2.1 Stimulants (Amphetamines, Methylphenidate) 3.1.2.2 Non-Stimulants 3.1.2.3 Antidepressants 3.1.3 Eli Lilly ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Eli Lilly Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Eli Lilly ADHD Drugs Volume in Different Applications and Its Application Share 3.2 Janssen Pharmaceuticals, Inc. 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 ADHD Drugs Product Category, Application and Specification 3.2.2.1 Stimulants (Amphetamines, Methylphenidate) 3.2.2.2 Non-Stimulants 3.2.2.3 Antidepressants 3.2.3 Janssen Pharmaceuticals, Inc. ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Janssen Pharmaceuticals, Inc. Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Different Applications and Its Application Share 3.3 Shire 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 ADHD Drugs Product Category, Application and Specification 3.3.2.1 Stimulants (Amphetamines, Methylphenidate) 3.3.2.2 Non-Stimulants 3.3.2.3 Antidepressants 3.3.3 Shire ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Shire Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Shire ADHD Drugs Volume in Different Applications and Its Application Share 3.4 Perdue Pharma 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 ADHD Drugs Product Category, Application and Specification 3.4.2.1 Stimulants (Amphetamines, Methylphenidate) 3.4.2.2 Non-Stimulants 3.4.2.3 Antidepressants 3.4.3 Perdue Pharma ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Perdue Pharma Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Perdue Pharma ADHD Drugs Volume in Different Applications and Its Application Share 3.5 Glaxosmith Kline 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 ADHD Drugs Product Category, Application and Specification 3.5.2.1 Stimulants (Amphetamines, Methylphenidate) 3.5.2.2 Non-Stimulants 3.5.2.3 Antidepressants 3.5.3 Glaxosmith Kline ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Glaxosmith Kline Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Glaxosmith Kline ADHD Drugs Volume in Different Applications and Its Application Share 3.6 Novartis 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 ADHD Drugs Product Category, Application and Specification 3.6.2.1 Stimulants (Amphetamines, Methylphenidate) 3.6.2.2 Non-Stimulants 3.6.2.3 Antidepressants 3.6.3 Novartis ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novartis Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novartis ADHD Drugs Volume in Different Applications and Its Application Share 3.7 Celltech Group 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 ADHD Drugs Product Category, Application and Specification 3.7.2.1 Stimulants (Amphetamines, Methylphenidate) 3.7.2.2 Non-Stimulants 3.7.2.3 Antidepressants 3.7.3 Celltech Group ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Celltech Group Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Celltech Group ADHD Drugs Volume in Different Applications and Its Application Share 3.8 Johnson & Johnson 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 ADHD Drugs Product Category, Application and Specification 3.8.2.1 Stimulants (Amphetamines, Methylphenidate) 3.8.2.2 Non-Stimulants 3.8.2.3 Antidepressants 3.8.3 Johnson & Johnson ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Johnson & Johnson Different Types of ADHD Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Johnson & Johnson ADHD Drugs Volume in Different Applications and Its Application Share 3.9.2.1 Stimulants (Amphetamines, Methylphenidate) 3.9.2.2 Non-Stimulants 3.9.2.3 Antidepressants 3.10.2.1 Stimulants (Amphetamines, Methylphenidate) 3.10.2.2 Non-Stimulants 3.10.2.3 Antidepressants 4 Global ADHD Drugs Market Competition by Manufacturers 4.1 Global ADHD Drugs Capacity, Production and Share by Manufacturers (2012-2017) 4.1.1 Global ADHD Drugs Capacity (K Units) and Share (%) by Manufacturers (2012-2017) 4.1.2 Global ADHD Drugs Production (K Units) and Share (%) by Manufacturers (2012-2017) 4.2 Global ADHD Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Global ADHD Drugs Average Price (USD/Unit) by Manufacturers (2012-2017) 4.4 Manufacturers ADHD Drugs Manufacturing Base Distribution, Sales Area, Product Types 4.5 ADHD Drugs Market Competitive Situation and Trends 4.5.1 ADHD Drugs Market Concentration Rate 4.5.2 ADHD Drugs Market Share (%) of Top 3 and Top 5 Manufacturers 5 Global ADHD Drugs Production by Regions (2012-2017) 5.1 Global ADHD Drugs Capacity (K Units) and Market Share (%) by Regions (2012-2017) 5.2 Global ADHD Drugs Production (K Units) and Market Share (%) by Regions (2012-2017) 5.3 Global ADHD Drugs Revenue and Market Share (%) by Regions (2012-2017) 5.4 Global ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.5 North America ADHD Drugs Production (2012-2017) 5.5.1 North America ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.5.2 North America ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.6 Europe ADHD Drugs Production (2012-2017) 5.6.1 Europe ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.6.2 Europe ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.7 China ADHD Drugs Production (2012-2017) 5.7.1 China ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.7.2 China ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.8 Japan ADHD Drugs Production (2012-2017) 5.8.1 Japan ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.8.2 Japan ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.9 Southeast Asia ADHD Drugs Production (2012-2017) 5.9.1 Southeast Asia ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.9.2 Southeast Asia ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.10 India ADHD Drugs Production (2012-2017) 5.10.1 India ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.10.2 India ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 6 Global ADHD Drugs Consumption (K Units) by Regions (2012-2017) 6.1 Global ADHD Drugs Consumption (K Units) by Regions (2012-2017) 6.2 North America ADHD Drugs Consumption (K Units) by Regions (2012-2017) 6.3 Europe ADHD Drugs Consumption (K Units) by Regions (2012-2017) 6.4 China ADHD Drugs Consumption (K Units) by Regions (2012-2017) 6.5 Japan ADHD Drugs Consumption (K Units) by Regions (2012-2017) 7 Global ADHD Drugs Production, Revenue, Price Trend by Types 7.1 Global ADHD Drugs Production (K Units) and Market Share (%) by Types (2012-2017) 7.2 Global ADHD Drugs Revenue (Million USD) and Market Share (%) by Types (2012-2017) 7.3 Global ADHD Drugs Price (USD/Unit) by Type (2012-2017) 7.4 Global ADHD Drugs Production Growth (%) by Type (2012-2017) 8 Global Market Analysis by Applications 8.1 Global Consumption (K Units) and Market Share (%) by Applications (2012-2017) 8.2 Global Consumption Growth Rate by Applications (2012-2017) 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Global ADHD Drugs Market Forecast (2018-2023) 10.1 Global ADHD Drugs Capacity, Production, Revenue Forecast (2018-2023) 10.1.1 Global ADHD Drugs Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) 10.1.2 Global ADHD DrugsRevenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 10.1.3 Global ADHD Drugs Price and Trend Forecast (2018-2023) 10.2 Global ADHD Drugs Production (K Units) Forecast by Regions (2018-2023) 10.2.1 North America ADHD Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.2 Europe ADHD Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.3 China ADHD Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.4 Japan ADHD Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.5 Southeast Asia ADHD Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.6 India ADHD Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.3 Global ADHD Drugs Consumption (K Units) Forecast by Regions (2018-2023) 10.3.1 North America ADHD Drugs Consumption (K Units) Forecast (2018-2023) 10.3.2 Europe ADHD Drugs Consumption (K Units) Forecast (2018-2023) 10.3.3 China ADHD Drugs Consumption (K Units) Forecast (2018-2023) 10.3.4 Japan ADHD Drugs Consumption (K Units) Forecast (2018-2023) 10.3.5 Southeast Asia ADHD Drugs Consumption (K Units) Forecast (2018-2023) 10.3.6 India ADHD Drugs Consumption (K Units) Forecast (2018-2023) 10.4 Global ADHD Drugs Production, Revenue and Price Forecast by Type (2018-2023) 10.5 Global ADHD Drugs Consumption Forecast by Application (2018-2023) 11 Research Findings and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Disclaimer 12.4 Author List

List of Tables and Figures Figure Global ADHD Drugs Market Size (Million USD) Status and Outlook 2012-2023 Table ADHD Drugs Production (K Units) and Revenue (Million USD) Market Split by Product Type Table ADHD Drugs Consumption (K Units) by Application (2017-2023) Figure Picture of ADHD Drugs Figure Global ADHD Drugs Production Market Share (%) by Types in 2016 Figure Global ADHD Drugs Production Market Share (%) by Subclasses of Stimulants (Amphetamines, Methylphenidate) in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global ADHD Drugs Production Market Share (%) by Subclasses of Non-Stimulants in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global ADHD Drugs Production Market Share (%) by Subclasses of Antidepressants in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Table Global ADHD Drugs Consumption (K Units) Comparison by Applications (2012-2023) Table Global ADHD Drugs Consumption (USD/Unit) Market Share (%) by Applications in 2016 Figure Adults Examples Figure Children Examples Figure New Project SWOT Analysis of ADHD Drugs Table Industry News List of ADHD Drugs Figure Industry Chain Structure of ADHD Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/Unit) Figure Global Raw Material B Price Trend (USD/Unit) Figure Global Raw Material C Price Trend (USD/Unit) Table Manufacturing Cost Structure Analysis of ADHD Drugs in 2017 Figure Manufacturing Process Analysis of ADHD Drugs Table Raw Materials Sources of ADHD Drugs Major Manufacturers in 2017 Table Major Buyers of ADHD Drugs Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Eli Lilly ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Eli Lilly ADHD Drugs Production Market Share (%) (2012-2017) Figure Eli Lilly ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly ADHD Drugs Volume in Adults and Its Application Share Table Eli Lilly ADHD Drugs Volume in Children and Its Application Share Table Eli Lilly ADHD Drugs Volume in and Its Application Share Table Eli Lilly ADHD Drugs Volume in and Its Application Share Table Janssen Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Janssen Pharmaceuticals, Inc. ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Production Market Share (%) (2012-2017) Figure Janssen Pharmaceuticals, Inc. ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Adults and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in Children and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in and Its Application Share Table Janssen Pharmaceuticals, Inc. ADHD Drugs Volume in and Its Application Share Table Shire Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Shire ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Shire ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Shire ADHD Drugs Production Market Share (%) (2012-2017) Figure Shire ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Shire ADHD Drugs Volume in Adults and Its Application Share Table Shire ADHD Drugs Volume in Children and Its Application Share Table Shire ADHD Drugs Volume in and Its Application Share Table Shire ADHD Drugs Volume in and Its Application Share Table Perdue Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Perdue Pharma ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Production Market Share (%) (2012-2017) Figure Perdue Pharma ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Perdue Pharma ADHD Drugs Volume in Adults and Its Application Share Table Perdue Pharma ADHD Drugs Volume in Children and Its Application Share Table Perdue Pharma ADHD Drugs Volume in and Its Application Share Table Perdue Pharma ADHD Drugs Volume in and Its Application Share Table Glaxosmith Kline Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Glaxosmith Kline ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Production Market Share (%) (2012-2017) Figure Glaxosmith Kline ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Glaxosmith Kline ADHD Drugs Volume in Adults and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in Children and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in and Its Application Share Table Glaxosmith Kline ADHD Drugs Volume in and Its Application Share Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Novartis ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Novartis ADHD Drugs Production Market Share (%) (2012-2017) Figure Novartis ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis ADHD Drugs Volume in Adults and Its Application Share Table Novartis ADHD Drugs Volume in Children and Its Application Share Table Novartis ADHD Drugs Volume in and Its Application Share Table Novartis ADHD Drugs Volume in and Its Application Share Table Celltech Group Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Celltech Group ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Celltech Group ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Celltech Group ADHD Drugs Production Market Share (%) (2012-2017) Figure Celltech Group ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Celltech Group ADHD Drugs Volume in Adults and Its Application Share Table Celltech Group ADHD Drugs Volume in Children and Its Application Share Table Celltech Group ADHD Drugs Volume in and Its Application Share Table Celltech Group ADHD Drugs Volume in and Its Application Share Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Johnson & Johnson ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Johnson & Johnson ADHD Drugs Production Growth Rate (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Production Market Share (%) (2012-2017) Figure Johnson & Johnson ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson ADHD Drugs Volume in Adults and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in Children and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in and Its Application Share Table Johnson & Johnson ADHD Drugs Volume in and Its Application Share Table Basic Information, Manufacturing Base, Sales Area and Its Competitors Table ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure ADHD Drugs Production Growth Rate (%) (2012-2017) Figure ADHD Drugs Production Market Share (%) (2012-2017) Figure ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ADHD Drugs Volume in Adults and Its Application Share Table ADHD Drugs Volume in Children and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table Basic Information, Manufacturing Base, Sales Area and Its Competitors Table ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure ADHD Drugs Production Growth Rate (%) (2012-2017) Figure ADHD Drugs Production Market Share (%) (2012-2017) Figure ADHD Drugs Revenue Market Share (%) (2012-2017) Table Stimulants (Amphetamines, Methylphenidate) Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Stimulants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Antidepressants Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table ADHD Drugs Volume in Adults and Its Application Share Table ADHD Drugs Volume in Children and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table ADHD Drugs Volume in and Its Application Share Table Global ADHD Drugs Capacity (K Units) of Key Manufacturers (2012-2017) Table Global ADHD Drugs Capacity Market Share (%) of Key Manufacturers (2012-2017) Figure Global ADHD Drugs Capacity Market Share (%) of Key Manufacturers in 2017 Figure Global ADHD Drugs Capacity Market Share (%) of Key Manufacturers in 2017 Table Global ADHD Drugs Production (K Units) of Key Manufacturers (2012-2017) Table Global ADHD Drugs Production Share (%) by Manufacturers (2012-2017) Figure 2016 ADHD Drugs Production Share (%) by Manufacturers Figure 2016 ADHD Drugs Production Share (%) by Manufacturers Table Global ADHD Drugs Revenue (Million USD) by Manufacturers (2012-2017) Table Global ADHD Drugs Revenue Share (%) by Manufacturers (2012-2017) Table 2016 Global ADHD Drugs Revenue Share (%) by Manufacturers Table 2016 Global ADHD Drugs Revenue Share (%) by Manufacturers Table Global Market ADHD Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017) Figure Global Market ADHD Drugs Average Price (USD/Unit) of Key Manufacturers in 2017 Table Manufacturers ADHD Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers ADHD Drugs Product Category Figure ADHD Drugs Market Share (%) of Top 3 Manufacturers Figure ADHD Drugs Market Share (%) of Top 5 Manufacturers Table Global ADHD Drugs Capacity (K Units) by Regions (2012-2017) Figure Global ADHD Drugs Capacity Market Share (%) by Regions (2012-2017) Figure Global ADHD Drugs Capacity Market Share (%) by Regions (2012-2017) Figure 2016 Global ADHD Drugs Capacity Market Share (%) by Regions Table Global ADHD Drugs Production (K Units) by Regions (2012-2017) Figure Global ADHD Drugs Production Market Share (%) by Regions (2012-2017) Figure Global ADHD Drugs Production Market Share (%) by Regions (2012-2017) Figure 2016 Global ADHD Drugs Production Market Share (%) by Regions Table Global ADHD Drugs Revenue (Million USD) by Regions (2012-2017) Table Global ADHD Drugs Revenue Market Share (%) by Regions (2012-2017) Figure Global ADHD Drugs Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global ADHD Drugs Revenue Market Share (%) by Regions Figure Global ADHD Drugs Capacity, Production (K Units) and Growth Rate (2012-2017) Table Global ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure North America ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table North America ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Europe ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table Europe ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure China ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table China ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Japan ADHD Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table Japan ADHD Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Table Global ADHD Drugs Consumption (K Units) Market by Regions (2012-2017) Table Global ADHD Drugs Consumption Market Share (%) by Regions (2012-2017) Figure Global ADHD Drugs Consumption Market Share (%) by Regions (2012-2017) Figure 2016 Global ADHD Drugs Consumption Market Share (%) by Regions Figure North America ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure Europe ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure China ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure Japan ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure Southeast Asia ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure India ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure South America ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Figure Middle East ADHD Drugs Consumption and Growth Rate (%) (2012-2017) Table Global ADHD Drugs Production (K Units) by Types (2012-2017) Table Global ADHD Drugs Production Share (%) by Types (2012-2017) Figure Production Market Share (%) of ADHD Drugs by Types (2012-2017) Figure 2016 Production Market Share (%) of ADHD Drugs by Types Table Global ADHD Drugs Revenue (Million USD) by Types (2012-2017) Table Global ADHD Drugs Revenue Share (%) by Types (2012-2017) Figure Revenue Share (%) of ADHD Drugs by Types (2012-2017) Figure 2016 Revenue Market Share (%) of ADHD Drugs by Types Table Global ADHD Drugs Price (USD/Unit) by Types (2012-2017) Figure Global ADHD Drugs Production Growth (%) by Type (2012-2017) Table Global ADHD Drugs Consumption (K Units) by Applications (2012-2017) Table Global ADHD Drugs Consumption Market Share (%) by Applications (2012-2017) Figure Global ADHD Drugs Consumption Market Share (%) by Applications (2012-2017) Figure Global ADHD Drugs Consumption Market Share (%) by Applications in 2017 Table Global ADHD Drugs Consumption Growth Rate by Applications (2012-2017) Figure Global ADHD Drugs Consumption Growth Rate by Applications (2012-2017) Table Distributors/Traders List Figure Global ADHD Drugs Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Global ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Global ADHD Drugs Price and Trend Forecast (2018-2023) Table Global ADHD Drugs Production (K Units) Forecast by Regions (2018-2023) Figure Global ADHD Drugs Production Market Share (%) Forecast by Regions (2018-2023) Figure North America ADHD Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe ADHD Drugs Production (K Units) and Growth Rate Forecast (2018-2023) Figure Europe ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China ADHD Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan ADHD Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan ADHD Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Global ADHD Drugs Consumption (K Units) Forecast by Regions (2018-2023) Figure Global ADHD Drugs Consumption Market Share (%) Forecast by Regions (2018-2023) Figure North America ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South America ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Middle East ADHD Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Table Global ADHD Drugs Production (K Units) Forecast by Type (2018-2023) Figure Global ADHD Drugs Production Forecast by Type (2018-2023) Table Global ADHD Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Global ADHD Drugs Revenue Market Share (%) Forecast by Type (2018-2023) Table Global ADHD Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Global ADHD Drugs Consumption (K Units) Forecast by Application (2018-2023) Figure Global ADHD Drugs Consumption Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Eli Lilly Janssen Pharmaceuticals, Inc. Shire Perdue Pharma Glaxosmith Kline Novartis Celltech Group Johnson & Johnson